From: Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019
Generic name
Brand name
Indication
Year of approval by FDA
Tocilizumab
Actemra
RA, CRS, sJIA, Giant cell arteritis, COVID-19
2003; tocilizumab was granted an EUA for the treatment of COVID-19 in June 2021
Sarilumab
Kevzara
RA
2017